Key result
Higher BMI was significantly associated with increased systemic inflammation markers IL-6 (β 0.031) and hs-CRP (β 0.075), with these relationships being stronger in women than in men.
Why the study?
Ectopic fat deposition may contribute to chronic inflammation in people with HIV, but which fat measures relate to inflammation and whether sex or HIV status modifies this relationship was unknown.
Does ectopic fat deposition relate to systemic inflammation in people with treated HIV infection?
Cross-Sectional (n=125)
No
Does ectopic fat deposition relate to systemic inflammation in people with treated HIV infection?
Effect estimate: β 0.031 (95% CI 0.013-0.048)
p-value: p=0.001
Among people with treated HIV infection, higher BMI and excessive ectopic fat burden are associated with systemic inflammation, with the relationship appearing stronger in women than in men.
May inform sex-specific inflammation monitoring in treated HIV; leaves open causal cardiovascular effects.
Introduction: Ectopic fat deposition may contribute to chronic inflammation in people with HIV (PWH). To inform future mechanistic studies of metabolic risk in this population, we sought to determine which fat measures relate more strongly to inflammation and whether the fat-inflammation relationship is modified by sex or HIV status.Methods: We conducted a cross-sectional study of 105 PWH and 20 age- and sex-matched HIV-negative controls. Interleukin-6 (IL-6) and high-sensitivity C reactive protein (hs-CRP) levels were measured from plasma. Pericardial fat (PCF) and thoracic periaortic adipose tissue (TAT) volumes and peri-right coronary artery (RCA), left atrium (LA) roof and liver densities were measured from cardiac CT scans. Unadjusted and multivariate adjusted linear regression models were used to determine the relationship between ectopic fat measures and inflammation biomarkers.Results: Forty subjects had BMI <25, 33 had BMI 25-30, and 52 had BMI >30. Systolic blood pressure and insulin resistance increased with BMI. Subjects with higher BMI had higher CD4+ count. In models adjusted for demographics, HIV status and metabolic risk factors, BMI was positively associated with IL-6 and hs-CRP. Ectopic PCF and TAT volumes were positively associated with IL-6 and hs-CRP; however, these relationships were somewhat attenuated in adjusted models. LA roof (but not peri-RCA) fat radiodensity was inversely associated with hs-CRP in fully adjusted models and the association with IL-6 was borderline statistically significant. IL-6 was more strongly associated with BMI and LA roof density in women than in men (p for interaction=0.05).Conclusions: Among PWH on antiretroviral therapy, higher BMI and excessive visceral fat burden were associated with circulating markers of systemic inflammation, and this relationship appears to be stronger in women compared to men.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2019) conducted a cross-sectional in Treated HIV infection (n=125). Body mass index (BMI) and ectopic visceral fat was evaluated on Association of BMI with natural-log-transformed IL-6 (β 0.031, 95% CI 0.013-0.048, p=0.001). Higher BMI was significantly associated with increased systemic inflammation markers IL-6 (β 0.031) and hs-CRP (β 0.075), with these relationships being stronger in women than in men.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: